Your browser doesn't support javascript.
loading
Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
Peloquin, C A; Velásquez, G E; Lecca, L; Calderón, R I; Coit, J; Milstein, M; Osso, E; Jimenez, J; Tintaya, K; Garavito, E Sanchez; Vasquez, D Vargas; Mitnick, C D; Davies, G.
Afiliação
  • Peloquin CA; University of Florida College of Pharmacy and Emerging Pathogens Institute, Gainesville, Florida, USA.
  • Velásquez GE; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lecca L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Calderón RI; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Coit J; Socios En Salud, Lima, Peru.
  • Milstein M; Socios En Salud, Lima, Peru.
  • Osso E; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Jimenez J; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Tintaya K; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Garavito ES; Socios En Salud, Lima, Peru.
  • Vasquez DV; Socios En Salud, Lima, Peru.
  • Mitnick CD; Hospital Nacional Sergio Bernales, Lima, Peru.
  • Davies G; Hospital Nacional Hipólito Unanue, Lima, Peru.
Antimicrob Agents Chemother ; 61(9)2017 09.
Article em En | MEDLINE | ID: mdl-28839086
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article